Picture of RaQualia Pharma logo

4579 — RaQualia Pharma News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapFalling Star

Table: RaQualia Pharma -2017 group results

Feb 9 (Reuters)-  
          RaQualia Pharma Inc  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended        Year to        NEXT    
              Dec 31, 2017    Dec 31, 2016    Dec 31, 2018      YEAR      
                 LATEST         YEAR-AGO         COMPANY       COMPANY    
                 RESULTS         RESULTS        FORECAST     H1 FORECAST  
  Sales           1.42                            1.39                    
                                               (-2.2 pct)                 
  Operating   loss 150 mln                    loss 698 mln                
  Recurring    loss 80 mln                    loss 680 mln                
  Net 
  Net          loss 58 mln                    loss 686 mln                
  EPS         loss 2.99 yen                  loss 33.84 yen               
  Ann Div          NIL             NIL             NIL                    
  -Q2 Div          NIL             NIL             NIL                    
  -Q4 Div          NIL             NIL             NIL                    
   
  NOTE - RaQualia Pharma Inc. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on RaQualia Pharma

See all news